Keyphrases
Gonadotropin-releasing Hormone
100%
Fertility Preservation
100%
Chemotherapy
50%
Doxorubicin
50%
Cyclophosphamide
50%
Anti-mullerian Hormone Levels
50%
Anti-Müllerian Hormone
50%
Serum anti-Müllerian Hormone
50%
Vascular Endothelial Growth Factor
37%
Blood Samples
25%
Immunohistochemistry
25%
Protein Extraction
25%
RNA Extraction
25%
Ovarian Damage
25%
Chemotherapy Treatment
25%
Ovarian Reserve
25%
Immunoblotting
12%
Quantitative PCR
12%
Apoptosis
12%
In Vitro Culture
12%
Immunofluorescence
12%
Chemotherapy-induced
12%
Protective Effect
12%
Paucity
12%
Infertility
12%
Vascular Injury
12%
In Vitro Model
12%
CD34
12%
Clinical Protocols
12%
In Vivo Model
12%
Post-chemotherapy
12%
Neovascularization
12%
Factor Level
12%
Clinical Evidence
12%
Granulosa Cells
12%
ELISA Assay
12%
Long-term Decline
12%
Phosphorylated Akt
12%
End-labelling
12%
Wistar
12%
Terminal Deoxynucleotidyl Transferase
12%
Prospective Evaluation
12%
GnRH Receptor
12%
Induced Mechanism
12%
Differential Mechanism
12%
Chemotherapy Agents
12%
Serial Measurements
12%
Longitudinal Follow-up
12%
P Factor
12%
Leuprolide Acetate
12%
Vascular Damage
12%
Ovarian Protection
12%
Imprinting Control Region
12%
Medicine and Dentistry
Fertility Preservation
100%
Gonadorelin Agonist
100%
Muellerian Inhibiting Factor
100%
Doxorubicin
40%
Hormone Determination
40%
Cyclophosphamide
40%
Vasculotropin
30%
In Vitro
20%
Injury
20%
Immunohistochemistry
20%
Blood Vessel Injury
20%
Ovarian Reserve
20%
Enzyme Linked Immunosorbent Assay
10%
Real-Time Polymerase Chain Reaction
10%
Receptor
10%
Programmed Cell Death
10%
Immunoblotting
10%
Immunofluorescence
10%
Chemotherapy
10%
Chemotherapy Agent
10%
Granulosa Cell
10%
TUNEL Assay
10%
DNA Nucleotidylexotransferase
10%
Gonadotropin-Releasing Hormone
10%
Leuprorelin
10%
Biochemistry, Genetics and Molecular Biology
Gonadotropin-Releasing Hormone
100%
Agonist
100%
Anti-Müllerian Hormone
100%
Doxorubicin
40%
Cyclophosphamide
40%
Vascular Endothelial Growth Factor
30%
RNA Extraction
20%
Ovarian Reserve
20%
Western Blot
10%
Eicosanoid Receptor
10%
Mouse
10%
Gonadotropin-Releasing Hormone
10%
Real-Time Polymerase Chain Reaction
10%
Immunofluorescence
10%
CD34
10%
Neovascularization (Pathology)
10%
Terminal Deoxynucleotidyl Transferase
10%
TUNEL Assay
10%
Pharmacology, Toxicology and Pharmaceutical Science
Gonadorelin Agonist
100%
Muellerian Inhibiting Factor
100%
Chemotherapy
70%
Cyclophosphamide
40%
Doxorubicin
40%
Vasculotropin
30%
Injury
20%
Blood Vessel Injury
20%
Western Blot
10%
Mouse
10%
Receptor
10%
Enzyme-Linked Immunosorbent Assay
10%
Neovascularization (Pathology)
10%
Chemotherapy Agent
10%
DNA Nucleotidylexotransferase
10%
Leuprorelin
10%
Veterinary Science and Veterinary Medicine
Gonadotropin-Releasing Hormone Agonist
100%
Anti-Müllerian Hormone
100%
Doxorubicin
40%
Vascular Endothelial Growth Factor
30%
Rat
10%
Mouse
10%
Gonadotropin-Releasing Hormone
10%
Granulosa Cell
10%
Leuprorelin
10%